Epstein-Barr virus-induced gene 3 (EBI3) can mediate IL-6 trans-signaling

Journal of Biological Chemistry

Volumn 292, Issue 16, 2017, Pages 6644-6656

  Chehboun, Salma ^a   Labrecque Carbonneau, Jérémie ^b   Pasquin, Sarah ^a   Meliani, Yasmine ^a   Meddah, Bouchra ^c   Ferlin, Walter ^d   Sharma, Mukut ^e   Tormo, Aurélie ^a   Masson, Jean François ^b   Gauchat, Jean François ^a  

^a Dept de Pédiatrie   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MOHAMMED V UNIVERSITY   (Morocco)

^d NovImmune   (Switzerland)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD VESSELS; CELL CULTURE; CELL SIGNALING; ENDOTHELIAL CELLS; GENES; SIGNALING; VIRUSES;

AUTOIMMUNE DISEASE; CO-IMMUNOPRECIPITATIONS; CYTOKINE RECEPTOR; EPSTEIN-BARR VIRUS; INDEPENDENT FUNCTIONS; PLASMACYTOMA; THERAPEUTIC USE; TRANSFECTANTS;

IMMUNOLOGY;

CYTOKINE; EPSTEIN BARR VIRUS INDUCED GENE 3; GLYCOPROTEIN GP 130; HYBRID PROTEIN; INTERLEUKIN 27; INTERLEUKIN 35; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR ALPHA; MESSENGER RNA; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; PROTEIN P28; PROTEIN P35; STAT3 PROTEIN; UNCLASSIFIED DRUG; CHEMOKINE; CYTOKINE RECEPTOR; EBI3 PROTEIN, MOUSE; IL27 PROTEIN, MOUSE; IL6ST PROTEIN, MOUSE; INTERLEUKIN 6 RECEPTOR; INTERLEUKIN DERIVATIVE; INTERLEUKIN-6, MOUSE; MINOR HISTOCOMPATIBILITY ANTIGEN; PROTEIN BINDING;

ANIMAL CELL; ARTICLE; AUTOIMMUNE DISEASE; C57BL 6 MOUSE; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PLASMACYTOMA CELL LINE; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; VASCULAR ENDOTHELIAL CELL; ANIMAL; C57BL MOUSE; CHEMISTRY; HEK293 CELL LINE; INFLAMMATION; METABOLISM; PHOSPHORYLATION; PLASMACYTOMA; TUMOR CELL LINE; UMBILICAL VEIN ENDOTHELIAL CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL LINE, TUMOR; CELL PROLIFERATION; CHEMOKINES; CYTOKINE RECEPTOR GP130; FEMALE; HEK293 CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; INTERLEUKIN-6; INTERLEUKINS; MICE; MICE, INBRED C57BL; MINOR HISTOCOMPATIBILITY ANTIGENS; PHOSPHORYLATION; PLASMACYTOMA; PROTEIN BINDING; RECEPTORS, CYTOKINE; RECEPTORS, INTERLEUKIN-6; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION;

EID: 85018585730     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M116.762021     Document Type: Article

References (52)

1. Jones, L. L., and Vignali, D. A. (2011) Molecular interactions within the IL-6/IL-12 cytokine/receptor superfamily. Immunol. Res. 51, 5-14
2. Devergne, O., Hummel, M., Koeppen, H., Le Beau, M. M., Nathanson, E. C., Kieff, E., and Birkenbach, M. (1996) A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. J. Virol. 70, 1143-1153
3. Devergne, O., Coulomb-L'Herminé, A., Capel, F., Moussa, M., and Capron, F. (2001) Expression of Epstein-Barr virus-induced gene 3, an interleukin-12 p40-related molecule, throughout human pregnancy: involvement of syncytiotrophoblasts and extravillous trophoblasts. Am. J. Pathol. 159, 1763-1776
4. Pflanz, S., Timans, J. C., Cheung, J., Rosales, R., Kanzler, H., Gilbert, J., Hibbert, L., Churakova, T., Travis, M., Vaisberg, E., Blumenschein, W. M., Mattson, J. D., Wagner, J. L., To, W., Zurawski, S., et al. (2002) IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4-T cells. Immunity 16, 779-790
5. Devergne, O., Birkenbach, M., and Kieff, E. (1997) Epstein-Barr virusinduced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin. Proc. Natl. Acad. Sci. U.S.A. 94, 12041-12046
6. Vignali, D. A., and Kuchroo, V. K. (2012) IL-12 family cytokines: immunological playmakers. Nat. Immunol. 13, 722-728
7. Pirhonen, J., Sirén, J., Julkunen, I., and Matikainen, S. (2007) IFN-regulates Toll-like receptor-mediated IL-27 gene expression in human macrophages. J. Leukoc. Biol. 82, 1185-1192
8. Pflanz, S., Hibbert, L., Mattson, J., Rosales, R., Vaisberg, E., Bazan, J. F., Phillips, J. H., McClanahan, T. K., de Waal Malefyt, R., and Kastelein, R. A. (2004) WSX-1 and glycoprotein 130 constitute a signal-Transducing receptor for IL-27. J. Immunol. 172, 2225-2231
9. Bosmann, M., and Ward, P. A. (2013) Modulation of inflammation by interleukin-27. J. Leukoc. Biol. 94, 1159-1165
10. Freitas do Rosário, A. P., Lamb, T., Spence, P., Stephens, R., Lang, A., Roers, A., Muller, W., O'Garra, A., and Langhorne, J. (2012) IL-27 promotes IL-10 production by effector Th1 CD4 T cells: A critical mechanism for protection from severe immunopathology during malaria infection. J. Immunol. 188, 1178-1190
11. Stumhofer, J. S., Laurence, A., Wilson, E. H., Huang, E., Tato, C. M., Johnson, L. M., Villarino, A. V., Huang, Q., Yoshimura, A., Sehy, D., Saris, C. J., O'Shea, J. J., Hennighausen, L., Ernst, M., and Hunter, C. A. (2006) Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat. Immunol. 7, 937-945
12. Batten, M., Li, J., Yi, S., Kljavin, N. M., Danilenko, D. M., Lucas, S., Lee, J., de Sauvage, F. J., and Ghilardi, N. (2006) Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat. Immunol. 7, 929-936
13. Liu, Z., Yu, J., Carson W. E, 3rd, Bai, X. F. (2013) The role of IL-27 in the induction of anti-Tumor cytotoxic T lymphocyte response. Am. J. Transl. Res. 5, 470-480
14. Li, X., Mai, J., Virtue, A., Yin, Y., Gong, R., Sha, X., Gutchigian, S., Frisch, A., Hodge, I., Jiang, X., Wang, H., and Yang, X. F. (2012) IL-35 is a novel responsive anti-inflammatory cytokine: A new system of categorizing antiinflammatory cytokines. PLoS One 7, e33628
15. Collison, L. W., Chaturvedi, V., Henderson, A. L., Giacomin, P. R., Guy, C., Bankoti, J., Finkelstein, D., Forbes, K., Workman, C. J., Brown, S. A., Rehg, J. E., Jones, M. L., Ni, H. T., Artis, D., et al. (2010) IL-35-mediated induction of a potent regulatory T cell population. Nat. Immunol. 11, 1093-1101
16. Wang, R. X., Yu, C. R., Dambuza, I. M., Mahdi, R. M., Dolinska, M. B., Sergeev, Y. V., Wingfield, P. T., Kim, S. H., and Egwuagu, C. E. (2014) Interleukin-35 induces regulatory B cells that suppress autoimmune disease. Nat. Med. 20, 633-641
17. Collison, L. W., Delgoffe, G. M., Guy, C. S., Vignali, K. M., Chaturvedi, V., Fairweather, D., Satoskar, A. R., Garcia, K. C., Hunter, C. A., Drake, C. G., Murray, P. J., and Vignali, D. A. (2012) The composition and signaling of the IL-35 receptor are unconventional. Nat. Immunol. 13, 290-299
18. Stumhofer, J. S., Tait, E. D., Quinn W. J., 3rd, Hosken, N., Spudy, B., Goenka, R., Fielding, C. A., O'Hara, A. C., Chen, Y., Jones, M. L., Saris, C. J., Rose-John, S., Cua, D. J., Jones, S. A., Elloso, M. M., et al. (2010) A role for IL-27p28 as an antagonist of gp130-mediated signaling. Nat. Immunol. 11, 1119-1126
19. Crabé, S., Guay-Giroux, A., Tormo, A. J., Duluc, D., Lissilaa, R., Guilhot, F., Mavoungou-Bigouagou, U., Lefouili, F., Cognet, I., Ferlin, W., Elson, G., Jeannin, P., and Gauchat, J. F. (2009) The IL-27 p28 subunit binds cytokine-like factor 1 to form a cytokine regulating NK and T cell activities requiring IL-6R for signaling. J. Immunol. 183, 7692-7702
20. Tormo, A. J., Meliani, Y., Beaupré, L. A., Sharma, M., Fritz, J. H., Elson, G., Crabé, S., and Gauchat, J. F. (2013) The composite cytokine p28/cytokinelike factor 1 sustains B cell proliferation and promotes plasma cell differentiation. J. Immunol. 191, 1657-1665
21. Jones, L. L., Chaturvedi, V., Uyttenhove, C., Van Snick, J., and Vignali, D. A. (2012) Distinct subunit pairing criteria within the heterodimeric IL-12 cytokine family. Mol. Immunol. 51, 234-244
22. Jana, M., Dasgupta, S., Pal, U., and Pahan, K. (2009) IL-12 p40 homodimer, the so-called biologically inactive molecule, induces nitric oxide synthase in microglia via IL-12R-1. Glia 57, 1553-1565
23. Brahmachari, S., and Pahan, K. (2008) Role of cytokine p40 family in multiple sclerosis. Minerva Med. 99, 105-118
24. Shimozato, O., Ugai, S., Chiyo, M., Takenobu, H., Nagakawa, H., Wada, A., Kawamura, K., Yamamoto, H., and Tagawa, M. (2006) The secreted form of the p40 subunit of interleukin (IL)-12 inhibits IL-23 functions and abrogates IL-23-mediated antitumour effects. Immunology 117, 22-28
25. Mondal, S., Roy, A., and Pahan, K. (2009) Functional blocking monoclonal antibodies against IL-12p40 homodimer inhibit adoptive transfer of experimental allergic encephalomyelitis. J. Immunol. 182, 5013-5023
26. Diamant, M., Hansen, M. B., Rieneck, K., Svenson, M., Yasukawa, K., and Bendtzen, K. (1994) Stimulation of the B9 hybridoma cell line by soluble interleukin-6 receptors. J. Immunol. Methods 173, 229-235
27. Thibault, V., Richards, C. D., Botelho, F., and Gauldie, J. (1997) Antibodies to rat soluble IL-6 receptor stimulate B9 hybridoma cell proliferation. FEBS Lett. 408, 182-186
28. Lacroix, M., Rousseau, F., Guilhot, F., Malinge, P., Magistrelli, G., Herren, S., Jones, S. A., Jones, G. W., Scheller, J., Lissilaa, R., Kosco-Vilbois, M., Johnson, Z., Buatois, V., and Ferlin, W. (2015) Novel insights into interleukin 6 (IL-6) cis-And trans-signaling pathways by differentially manipulating the assembly of the IL-6 signaling complex. J. Biol. Chem. 290, 26943-26953
29. Rousseau, F., Basset, L., Froger, J., Dinguirard, N., Chevalier, S., and Gascan, H. (2010) IL-27 structural analysis demonstrates similarities with ciliary neurotrophic factor (CNTF) and leads to the identification of antagonistic variants. Proc. Natl. Acad. Sci. U.S.A. 107, 19420-19425
30. Peters, M., Blinn, G., Solem, F., Fischer, M., Meyer zum Böschenfelde, K. H., and Rose-John, S. (1998) In vivo and in vitro activities of the gp130-stimulating designer cytokine hyper-IL-6. J. Immunol. 161, 3575-3581
31. Fischer, M., Goldschmitt, J., Peschel, C., Brakenhoff, J. P., Kallen, K. J., Wollmer, A., Grötzinger, J., and Rose-John, S. (1997) I. A bioactive designer cytokine for human hematopoietic progenitor cell expansion. Nat. Biotechnol. 15, 142-145
32. Sprecher, C. A., Grant, F. J., Baumgartner, J. W., Presnell, S. R., Schrader, S. K., Yamagiwa, T., Whitmore, T. E., O'Hara, P. J., and Foster, D. F. (1998) Cloning and characterization of a novel class I cytokine receptor. Biochem. Biophys. Res. Commun. 246, 82-90
33. Romano, M., Sironi, M., Toniatti, C., Polentarutti, N., Fruscella, P., Ghezzi, P., Faggioni, R., Luini, W., van Hinsbergh, V., Sozzani, S., Bussolino, F., receptor in induction of chemokines and leukocyte recruitment. Immunity 6, 315-325
34. Scheller, J., Chalaris, A., Schmidt-Arras, D., and Rose-John, S. (2011) The pro-And anti-inflammatory properties of the cytokine interleukin-6. Biochim. Biophys. Acta 1813, 878-888
35. Rose-John, S. (2012) IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6. Int. J. Biol. Sci. 8, 1237-1247
36. Garbers, C., Spudy, B., Aparicio-Siegmund, S., Waetzig, G. H., Sommer, J., Hölscher, C., Rose-John, S., Grötzinger, J., Lorenzen, I., and Scheller, J. (2013) An interleukin-6 receptor-dependent molecular switch mediates signal transduction of the IL-27 cytokine subunit p28 (IL-30) via a gp130 protein receptor homodimer. J. Biol. Chem. 288, 4346-4354
37. Larousserie, F., Bardel, E., Pflanz, S., Arnulf, B., Lome-Maldonado, C., Hermine, O., Brégeaud, L., Perennec, M., Brousse, N., Kastelein, R., and Devergne, O. (2005) Analysis of interleukin-27 (EBI3/p28) expression in Epstein-Barr virus-And human T-cell leukemia virus type 1-Associated lymphomas: heterogeneous expression of EBI3 subunit by tumoral cells. Am. J. Pathol. 166, 1217-1228
38. Hill, M., Thebault, P., Segovia, M., Louvet, C., Bériou, G., Tilly, G., Merieau, E., Anegon, I., Chiffoleau, E., and Cuturi, M. C. (2011) Cell therapy with autologous tolerogenic dendritic cells induces allograft tolerance through interferon- and Epstein-Barr virus-induced gene 3. Am. J. Transplant 11, 2036-2045
39. Maaser, C., Egan, L. J., Birkenbach, M. P., Eckmann, L., and Kagnoff, M. F. (2004) Expression of Epstein-Barr virus-induced gene 3 and other interleukin-12-related molecules by human intestinal epithelium. Immunology 112, 437-445
40. Chung, Y., Yamazaki, T., Kim, B. S., Zhang, Y., Reynolds, J. M., Martinez, G. J., Chang, S. H., Lim, H., Birkenbach, M., and Dong, C. (2013) Epstein Barr virus-induced 3 (EBI3) together with IL-12 negatively regulates T helper 17-mediated immunity to Listeria monocytogenes infection. PLoS Pathog. 9, e1003628
41. Liu, J. Q., Liu, Z., Zhang, X., Shi, Y., Talebian, F., Carl, J. W., Jr, Yu, C., Shi, F. D., Whitacre, C. C., Trgovcich, J., and Bai, X. F. (2012) Increased Th17 and regulatoryTcell responses in EBV-induced gene 3-deficient mice lead to marginally enhanced development of autoimmune encephalomyelitis. J. Immunol. 188, 3099-3106
42. Nieuwenhuis, E. E., Neurath, M. F., Corazza, N., Iijima, H., Trgovcich, J., Wirtz, S., Glickman, J., Bailey, D., Yoshida, M., Galle, P. R., Kronenberg, M., Birkenbach, M., and Blumberg, R. S. (2002) Disruption of T helper 2-immune responses in Epstein-Barr virus-induced gene 3-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 99, 16951-16956
43. Hou, T., Tieu, B. C., Ray, S., Recinos Iii, A., Cui, R., Tilton, R. G., and Brasier, A. R. (2008) Roles of IL-6-gp130 signaling in vascular inflammation. Curr. Cardiol. Rev. 4, 179-192
44. Chiesa, C., Pacifico, L., Natale, F., Hofer, N., Osborn, J. F., and Resch, B. (2015) Fetal and early neonatal interleukin-6 response. Cytokine 76, 1-12
45. Lee, S. Y., Buhimschi, I. A., Dulay, A. T., Ali, U. A., Zhao, G., Abdel-Razeq, S. S., Bahtiyar, M. O., Thung, S. F., Funai, E. F., and Buhimschi, C. S. (2011) IL-6 trans-signaling system in intra-Amniotic inflammation, preterm birth, and preterm premature rupture of the membranes. J. Immunol. 186, 3226-3236
46. Garbers, C., Hermanns, H. M., Schaper, F., Möller-Newen, G., Grötzinger, J., Rose-John, S., and Scheller, J. (2012) Plasticity and cross-Talk of interleukin 6-Type cytokines. Cytokine Growth Factor Rev. 23, 85-97
47. Tormo, A. J., Beaupré, L. A., Elson, G., Crabé, S., and Gauchat, J. F. (2013) Apolyglutamic acid motif confers IL-27 hydroxyapatite and bone-binding properties. J. Immunol. 190, 2931-2937
48. Cognet, I., Guilhot, F., Chevalier, S., Guay-Giroux, A., Bert, A., Elson, G. C., Gascan, H., and Gauchat, J. F. (2004) Expression of biologically active mouse ciliary neutrophic factor (CNTF) and soluble CNTFR- in Escherichia coli and characterization of their functional specificities. Eur. Cytokine Netw. 15, 255-262
49. Longo, P. A., Kavran, J. M., Kim, M. S., and Leahy, D. J. (2013) Transient mammalian cell transfection with polyethylenimine (PEI). Methods Enzymol. 529, 227-240
50. Szymczak, A. L., Workman, C. J., Wang, Y., Vignali, K. M., Dilioglou, S., Vanin, E. F., and Vignali, D. A. (2004) Correction of multi-gene deficiency in vivo using a single "self-cleaving" 2A peptide-based retroviral vector. Nat. Biotechnol. 22, 589-594
51. Zhao, S. S., Bukar, N., Toulouse, J. L., Pelechacz, D., Robitaille, R., Pelletier, J. N., and Masson, J. F. (2015) Miniature multi-channel SPR instrument for methotrexate monitoring in clinical samples. Biosens. Bioelectron 64, 664-670
52. Ratel, M., Provencher-Girard, A., Zhao, S. S., Breault-Turcot, J., Labrecque-Carbonneau, J., Branca, M., Pelletier, J. N., Schmitzer, A. R., and Masson, J. F. (2013) Imidazolium-based ionic liquid surfaces for biosensing. Anal. Chem. 85, 5770-5777